Sign in

CIK 0001262104

  • Non-accelerated filer
  • Smaller reporting company

Lite Strategy, Inc.

Sign in to watch
Ticker
LITS
Exchange
Nasdaq
Industry
Finance Services
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
510407811
Phone
+1 858-369-7100
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
Former names
MEI Pharma, Inc., MARSHALL EDWARDS INC
Open-market buys, last 90 days
$21,548
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$21,548. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Flynn James P +$22K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-07-05 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +350,000 350,000
2021-07-01 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2020-07-02 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +230,000 230,000
2019-12-19 Drazba Brian G. Chief Financial Officer Purchase +12,500 $1.60 $20K 37,500
2019-07-01 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +230,000 230,000
2018-07-12 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2018-06-22 Drazba Brian G. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +130,000 130,000
2017-07-06 Drazba Brian G. Chief Financial Officer Grant or award · Option to purchase shares of common stock +50,000 200,000
2017-04-03 Drazba Brian G. Chief Financial Officer Grant or award · Option to purchase shares of common stock +150,000 150,000

Page 1 of 1 · 9 trades